732 related articles for article (PubMed ID: 21965636)
41. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
[TBL] [Abstract][Full Text] [Related]
42. Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics.
Emir B; Murphy TK; Petersel DL; Whalen E
Expert Opin Pharmacother; 2010 Oct; 11(14):2275-80. PubMed ID: 20812879
[TBL] [Abstract][Full Text] [Related]
43. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial.
Buvanendran A; Kroin JS; Della Valle CJ; Kari M; Moric M; Tuman KJ
Anesth Analg; 2010 Jan; 110(1):199-207. PubMed ID: 19910619
[TBL] [Abstract][Full Text] [Related]
44. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Russell IJ; Perkins AT; Michalek JE;
Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
[TBL] [Abstract][Full Text] [Related]
45. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study.
North JM; Hong KS; Rauck RL
Pain Pract; 2016 Jul; 16(6):720-9. PubMed ID: 26059271
[TBL] [Abstract][Full Text] [Related]
46. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
47. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
[TBL] [Abstract][Full Text] [Related]
48. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.
Crofford LJ; Mease PJ; Simpson SL; Young JP; Martin SA; Haig GM; Sharma U
Pain; 2008 Jun; 136(3):419-431. PubMed ID: 18400400
[TBL] [Abstract][Full Text] [Related]
49. Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.
Cappelleri JC; Bushmakin AG; Zlateva G; Chandran A
J Med Econ; 2013; 16(1):55-61. PubMed ID: 22954060
[TBL] [Abstract][Full Text] [Related]
50. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
Rosenstock J; Tuchman M; LaMoreaux L; Sharma U
Pain; 2004 Aug; 110(3):628-638. PubMed ID: 15288403
[TBL] [Abstract][Full Text] [Related]
51. Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results.
Cappelleri JC; Bushmakin AG; Zlateva G; Sadosky A
Pain Pract; 2009; 9(5):348-53. PubMed ID: 19549060
[TBL] [Abstract][Full Text] [Related]
52. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
[TBL] [Abstract][Full Text] [Related]
53. Pregabalin for the treatment of abdominal adhesion pain: a randomized, double-blind, placebo-controlled trial.
Silverman A; Samuels Q; Gikas H; Nawras A
Am J Ther; 2012 Nov; 19(6):419-28. PubMed ID: 22020082
[TBL] [Abstract][Full Text] [Related]
54. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
[TBL] [Abstract][Full Text] [Related]
55. Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials.
Bhadra P; Petersel D
Expert Opin Pharmacother; 2010 Dec; 11(17):2805-12. PubMed ID: 21039311
[TBL] [Abstract][Full Text] [Related]
56. A randomized placebo-controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients.
Hargrove JB; Bennett RM; Simons DG; Smith SJ; Nagpal S; Deering DE
Pain Med; 2012 Jan; 13(1):115-24. PubMed ID: 22233397
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
Greist JH; Liu-Dumaw M; Schweizer E; Feltner D
Int Clin Psychopharmacol; 2011 Sep; 26(5):243-51. PubMed ID: 21734588
[TBL] [Abstract][Full Text] [Related]
58. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
Vinik A; Emir B; Cheung R; Whalen E
Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]